ARRDC3 and breast cancer: As mentioned earlier, ARRDC3 is known to participate in the negative regulation of the PAR1 receptor [127], which is overproduced in breast cancer cells [137], and aberrations in its signaling, for instance, due to dysregulation of lysosomal trafficking, influence metastasis [138].